GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
$0.0251
-0.0150 (-37.38%)
At Close: Apr 18, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.0200 $0.0500 Thursday, 18th Apr 2024 CALA stock ended at $0.0251. This is 37.38% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 0% from a day low at $0.0251 to a day high of $0.0251.
90 days $0.0200 $0.120
52 weeks $0.0100 $0.500

Historical Calithera Biosciences prices

Date Open High Low Close Volume
2023-10-18 $0.0400 $0.0400 $0.0400 $0.0400 1 046
2023-10-17 $0.0415 $0.0415 $0.0415 $0.0415 142
2023-10-16 $0.0400 $0.0400 $0.0400 $0.0400 0
2023-10-13 $0.0400 $0.0400 $0.0400 $0.0400 0
2023-10-12 $0.0400 $0.0425 $0.0400 $0.0400 1 925
2023-10-11 $0.0425 $0.0425 $0.0425 $0.0425 188
2023-10-10 $0.0500 $0.0505 $0.0500 $0.0505 1 941
2023-10-09 $0.0500 $0.0525 $0.0500 $0.0525 272
2023-10-06 $0.0510 $0.0510 $0.0510 $0.0510 1 059
2023-10-05 $0.0500 $0.0500 $0.0500 $0.0500 201
2023-10-04 $0.0500 $0.0500 $0.0500 $0.0500 0
2023-10-03 $0.0500 $0.0500 $0.0500 $0.0500 512
2023-10-02 $0.0500 $0.0500 $0.0500 $0.0500 2 799
2023-09-29 $0.0500 $0.0500 $0.0500 $0.0500 16 036
2023-09-28 $0.0500 $0.0500 $0.0500 $0.0500 781
2023-09-27 $0.0500 $0.0500 $0.0500 $0.0500 0
2023-09-26 $0.125 $0.125 $0.0500 $0.0500 310
2023-09-25 $0.0480 $0.0480 $0.0480 $0.0480 203
2023-09-22 $0.0500 $0.0500 $0.0500 $0.0500 550
2023-09-20 $0.0500 $0.0500 $0.0500 $0.0500 3 953
2023-09-19 $0.0500 $0.0500 $0.0500 $0.0500 0
2023-09-18 $0.0500 $0.100 $0.0500 $0.0500 1 456
2023-09-15 $0.0500 $0.0500 $0.0500 $0.0500 0
2023-09-14 $0.0500 $0.0500 $0.0500 $0.0500 0
2023-09-13 $0.0500 $0.0500 $0.0500 $0.0500 0
Click to get the best stock tips daily for free!

About Calithera Biosciences

Calithera Biosciences Calithera Biosciences, Inc., a clinical-stage bio-pharmaceutical company, focuses on the discovery and development of small molecule compounds for tumor metabolism and tumor immunology targets for the treatment of cancer in the United States. The company offers INCB001158, an orally bioavailable arginase inhibitor of arginase that is in Phase 1/2 clinical trial for the treatment of hematology and oncology. It is developing CB-280, an oral arginas... CALA Profile

Golden Star

Ticker Date Change Price
FTSL Apr 16 0.304% $46.08
FCN Apr 16 0.0096% $207.62
ELV Apr 16 3.59% $506.97
ITCI Apr 05 5.20% $68.44
AKR Apr 05 1.33% $16.53
SARK Mar 28 16.44% $26.88
ARCC Mar 25 1.49% $20.12
STT Mar 19 0.578% $72.62
BK Mar 19 0.0181% $55.24
LNC Mar 18 0.221% $27.17
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT